2020 American Transplant Congress
Tumor of Transplanted Kidney: Graft Resection Preserves Renal Function with Good Long-Term Oncologic Outcome
*Purpose: Incidence of urologic tumors is increased in renal transplant recipients. In case of a kidney transplant neoplasm, the graft-nephrectomy and hemodialysis reduce the quality…2020 American Transplant Congress
Failure to Launch; a Multi-Centre Study of Potential Live Donors in Southeast Nigeria
*Purpose: To determine the socio-demographic characteristics of potential living kidney donors, donor motivation, incidental findings on clinical evaluation and some identified factors that precluded eventual…2020 American Transplant Congress
The Long Term Impact of Metabolic Syndrome on Post-Donation in Living Kidney Donors
Division of Nephrology, Taichung Veterans General Hospital, Taichung, Taiwan
*Purpose: The long waiting list for kidney transplant (KTx) in Taiwan, the willingness of transplant centers increase to accept complex donors, eg. metabolic syndrome (MS).…2020 American Transplant Congress
Major Adverse Cardiovascular Events (MACE) in Living Kidney Donors (LKDs)
1Mayo Clinic, Rochester, MN, 2Mayo Clinic, Scottsdale, AZ
*Purpose: There is limited knowledge regarding long-term cardiovascular outcomes in living kidney donors. We performed a multicenter study assessing baseline risk factors that increase MACE…2020 American Transplant Congress
Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Therapy Prior to Kidney Transplantation Does Not Impact Recovery of Function
*Purpose: The impact of chronically administered medications for renin-angiotensin-aldosterone blockade (e.g. ACE-I, ARB), taken prior to kidney transplant (KTx), on immediate allograft function is unknown.*Methods:…2020 American Transplant Congress
Metabolic Syndrome Predicts Worse Long-Term Renal Outcomes in Living Kidney Donors (LKDs)
1Mayo Clinic, Rochester, MN, 2Mayo Clinic, Scottsdale, AZ
*Purpose: Prior studies linked metabolic syndrome with worse kidney outcomes in a variety of populations. In this study, we assessed the long-term risk of reduced…2020 American Transplant Congress
Long-Term Outcomes in Recipients of Allografts from Living Kidney Donors with Hypertension
1Medicine, Johns Hopkins, Baltimore, MD, 2Surgery, Johns Hopkins, Baltimore, MD
*Purpose: Allografts from living kidney donors may “carry” subclinical pathological abnormalities to the recipient and thus lead to adverse clinical outcomes. Because one mechanism underlying…2020 American Transplant Congress
Change in Hypertension (HTN) Guidelines in Living Kidney Donors (LKDs) and Long-Term Renal Outcomes
1Mayo Clinic Rochester, Rochester, MN, 2Mayo Clinic Rochester, Scottsdale, AZ
*Purpose: There is limited knowledge regarding the long-term renal outcomes in hypertensive LKDs. We performed a multicenter study assessing long-term outcomes with or without HTN…2020 American Transplant Congress
Living Donor Nephrectomy Outcomes in the Us: Analysis of HCUP Data
*Purpose: To identify clinical outcomes and complications of living donor nephrectomies in the US from 2008 - 2015.*Methods: A retrospective analysis of 2008-2015 discharge data…2020 American Transplant Congress
ESRD Risk Prediction for Black vs. White Related Living Kidney Donors
1Research, UNOS, Richmond, VA, 2Chief Medical Officer, UNOS, Richmond, VA
*Purpose: We studied 25-year risk of post-donation ESRD in black (n=10,214) and white (n=45,700) first-degree related living kidney donors (RLKDs) who donated in the US…
- « Previous Page
- 1
- …
- 500
- 501
- 502
- 503
- 504
- …
- 1683
- Next Page »